Objectives: The video demonstrates the anatomical relations and the important steps in the surgical treatment of type 3 popliteal entrapment. This is the second leg treated in this young adult. It concludes with this anomaly shown on magnetic resonance imaging in four of the patient's male relatives.
Objectives: Ipsilateral internal carotid artery bypass has been successfully used to treat aneurysms, infection, tumor, and occlusive disease. The purpose of this study was to evaluate the long-term outcomes of autogenous and prosthetic conduits used for ipsilateral internal carotid artery bypass.
Methods: A retrospective review of a single institution registry was performed to identify patients with ipsilateral carotid artery bypass. Demographics, complications, and patency were recorded and compared using c 2 , Fisher exact, and log-rank analysis. Results: From 1994 to 2016, 105 patients underwent ipsilateral carotid artery bypass (86 prosthetic, 19 veins) . The venous bypass group (VBG) and prosthetic bypass group (PBG) were different in terms of gender (8 men and 11 women vs 58 men and 28 women; P ¼.038) but were similar in age (mean VGB: 63 years; range, 18-80; PBG: 68 years; range, 33-88; P ¼ .052). Mean follow-up was 53 months (range, 1 month-15 years). Diabetes, pulmonary disease, hypercholesterolemia, and tobacco use was not statistically significant between groups. Indications were different between groups, with more PBG used for occlusive disease and more VBG used for infection, aneurysm, trauma, and tumor (Fisher exact test P ¼ .004). There were 81 prosthetic bypasses performed for occlusive disease which was Objectives: In 2016, pancreatic cancer became the third leading cause of cancer-related death in the United States. While 5-year survival rates remain in the single digits, surgical resection offers the only potential for cure and can increase survival tenfold. As such, patients with portomesenteric vein involvement benefit from surgical resection with portomesenteric vein reconstruction (PVR). Studies demonstrate the feasibility of PVR with femoral and/or saphenous vein conduits; however, femoral vein (FV) harvest is associated with increased risk of deep vein thrombosis (DVT) and wound complications. Cryopreserved FV may be a reasonable alternative avoiding such morbidity. We sought to compare outcomes of autogenous vs cryopreserved FV conduit in patients undergoing PVR during pancreaticoduodenectomy.
Methods: This was a retrospective review of our National Surgical Quality Improvement Program database for all patients undergoing pancreaticoduodenectomy with PVR from January 2010 to July 2016. Patient demographics (age, sex, and comorbidities) and tumor stage and pathology records were assessed. Postoperative complications, conduit patency, and perioperative mortality were compared between autogenous and cryopreserved vein groups.
Results: A total of 48 patients, 26 autogenous and 22 cryopreserved vein, underwent PVR. Demographics were similar between groups, although the autogenous vein group consisted of significantly more patients with diabetes (48% vs 14%; P ¼ .015). Median follow-up was 6.7 months. Median survival was 24 months between both groups. Tumor stage did not differ significantly between groups. Conduit patency (Fig 1) and overall survival (Fig 2) did not differ between groups. While surgical site infection rates did not differ between the groups (7% v 0%; P ¼ .493), there was a significantly higher rate of perioperative DVT in the autogenous vein group (57% v 14%; P ¼ .002). These DVTs were notably more likely to be proximal to the site of FV harvest. There were no conduit infections in either group. Univariate analysis demonstrated autogenous vein conduit and diabetes mellitus were independent predictors of perioperative DVT.
Conclusions: Patients undergoing oncologic pancreatic resection with PVR do not have significantly different patency or survival rates regardless of the conduit used. Since autogenous vein harvest is associated with significantly higher rates of perioperative DVT, cryopreserved vein should be considered for all PVR in pancreatic resection as it avoids the morbidity associated with autogenous vein harvest. 
